Interim results of clinician-rated symptom endpoints of a long-term, open-label study of levodopa-carbidopa intestinal gel in Parkinson's disease patients with severe motor fluctuations

被引：0
|
作者：
Fernandez, H. H.
Espay, A. J.
Standaert, D. G.
Benesh, J.
Lenz, R. A.
Caras, S. D.
Pritchett, Y. L.
Chatamra, K.
机构：
来源：
MOVEMENT DISORDERS | 2011年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
376
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [1] Interim results of safety endpoints of an open-label, long-term safety study of levodopa-carbidopa intestinal gel in Parkinson's disease patients with severe motor fluctuations
    Vanagunas, A.
    Chatamra, K.
    Standaert, D. G.
    Espay, J.
    Fernandez, H. H.
    Benesh, J.
    Caras, S. D.
    Robieson, W. Z.
    Lenz, R. A.
    MOVEMENT DISORDERS, 2011, 26 : S144 - S144
  • [2] Interim results of motor-symptom endpoints of an ongoing, open-label study of levodopa-carbidopa intestinal gel in Parkinson's disease patients with severe motor fluctuations
    Espay, A. J.
    Chatamra, K.
    Fernandez, H. H.
    Standaert, D. G.
    Hauser, R. A.
    Benesh, J.
    Caras, S. D.
    Pritchett, Y. L.
    Lenz, R. A.
    MOVEMENT DISORDERS, 2011, 26 : S126 - S126
  • [3] Levodopa-carbidopa intestinal gel in Parkinson's disease patients with severe motor fluctuations: Interim safety and motor-symptom endpoints in an ongoing, open-label study
    Espay, A. J.
    Vanagunas, A. D.
    Hauser, R. A.
    Fernandez, H. H.
    Standaert, D. G.
    Odin, P.
    Pritchett, Y.
    Widnell, K. L.
    Chatamra, K.
    Benesh, J.
    Lenz, R. A.
    MOVEMENT DISORDERS, 2012, 27 : S117 - S117
  • [4] Interim results of quality-of-life endpoints of an open-label study of levodopa-carbidopa intestinal gel in Parkinson's disease patients with severe motor fluctuations
    Standaert, D. G.
    Espay, A. J.
    Fernandez, H. H.
    Benesh, J.
    Lenz, R. A.
    Pritchett, Y. L.
    Hass, S.
    Chatamra, K.
    MOVEMENT DISORDERS, 2011, 26 : S141 - S142
  • [5] Levodopa-carbidopa intestinal gel in Parkinson's disease patients with severe motor fluctuations: Interim quality-of-life endpoints in an ongoing, open-label study
    Standaert, D. G.
    Fernandez, H. H.
    Odin, P.
    Hauser, R. A.
    Espay, A. J.
    Hass, S.
    Robieson, W. Z.
    Widnell, K. L.
    Chatamra, K.
    Benesh, J.
    MOVEMENT DISORDERS, 2012, 27 : S140 - S140
  • [6] Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results
    Fernandez, Hubert H.
    Vanagunas, Arvydas
    Odin, Per
    Espay, Alberto J.
    Hauser, Robert A.
    Standaert, David G.
    Chatamra, Krai
    Benesh, Janet
    Pritchett, Yili
    Hass, Steven L.
    Lenz, Robert A.
    PARKINSONISM & RELATED DISORDERS, 2013, 19 (03) : 339 - 345
  • [7] INTERIM RESULTS FROM AN ONGOING, LONG-TERM, OPEN-LABEL, EFFICACY AND SAFETY STUDY OF LEVODOPA/CARBIDOPA INTESTINAL GEL IN PATIENTS WITH PARKINSON'S DISEASE AND SEVERE MOTOR FLUCTUATIONS
    Odin, P.
    Chatamra, K.
    Espay, A. J.
    Standaert, D. G.
    Fernandez, H. H.
    Benesh, J.
    Robieson, W.
    Hass, S. L.
    Lenz, R. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 241 - 241
  • [8] Interim results from an international, open-label study of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: efficacy results by country
    Odin, P.
    Espay, A. J.
    Vanagunas, A. D.
    Hauser, R. A.
    Fernandez, H. H.
    Standaert, D. G.
    Robieson, W. Z.
    Pritchett, Y.
    Widnell, K. L.
    Chatamra, K.
    Benesh, J.
    Lenz, R. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 283 - 283
  • [9] Interim Results from an International, Open-Label Study of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson's Disease: Efficacy Analyses by Subgroups
    Odin, Per
    Espay, Alberto
    Vanagunas, Arvydas
    Hauser, Robert
    Fernandez, Hubert
    Standaert, David
    Robieson, Weining
    Pritchett, Yili
    Widnell, Katherine
    Chatamra, Krai
    Benesh, Janet
    Lenz, Robert
    NEUROLOGY, 2013, 80
  • [10] Percutaneous Endoscopic Gastrojejunostomy as a Novel Method of Drug Delivery for the Treatment of Parkinson's Disease: Interim Results of an Open-Label, Long-Term Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel
    Vanagunas, Arvydas
    Smallfield, George
    Schmulewitz, Nathan
    Crookes, Peter
    Benesh, Janet
    Freeman, Stefanie
    Robieson, Weining
    Chatamra, Krai
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S545 - S545
12345